Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors

BACKGROUND: Reference-based pricing is a cost-containment policy applied to prescription drugs that are in the same class and deemed to be therapeutically equivalent. Recent reference-based pricing measures have targeted several drug classes, including angiotensin-converting-enzyme (ACE) inhibitors....

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bourgault, C, Elstein, E, Le Lorier, J, Suissa, S
Формат: Artigo
Язык:Inglês
Опубликовано: 1999
Предметы:
Evidence
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1230501/
https://ncbi.nlm.nih.gov/pubmed/10463046
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы